[117] Schlegel PN, Sigmán M, Collura B, De Jonge CJ, Eisenberg ML, Lamb DJ, et al. Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I. Fertil Steril 2021;115(1):54–61. http://dx.doi.org/10.1016/j.fertns-tert.2020.11.015.

[118] Bujan L, Mieusset R, Mansat A, Moatti JP, Mondinat C, Pontonnier F. Testicular size in infertile men: relationship to semen characteristics and hormonal blood levels. Br J Urol 1989;64(6):632–7. http://dx.doi.org/10.1111/j.1464-410x.1989.tb05325.x.

[119] Walsh TJ, Croughan MS, Schembri M, Chan JM, Turek PJ. Increased risk of testicular germ cell cancer among infertile men. Arch Intern Med 2009;169(4):351–6. http://dx.doi.org/10.1001/archinternmed.2008.562.

[120] Hanson BM, Eisenberg ML, Hotaling JM. Male infertility: a biomarker of individual and familial cancer risk. Fertil Steril 2018;109(1):6–19. http://dx.doi.org/10.1016/j.fertnstert.2017.11.005.

[121] Hanson HA, Anderson RE, Aston KI, Carrell DT, Smith KR, Hotaling JM. Subfertility increases risk of testicular cancer: evidence from population-based semen samples. Fertil Steril 2016;105(2):322–8. http://dx.doi.org/10.1016/j.fertnstert.2015.10.027 [e1].

[122] Lagabrielle S, Durand S, Droupy S, Izard V, Marcelli F, Huyghe E, et al. Testicular tumours discovered during infertility workup are predominantly benign and could initially be managed by sparing surgery. J Surg Oncol 2018;118(4):630–5. http://dx.doi.org/10.1002/jso.25203.

[123] Oliva A, Multigner L. Chronic epididymitis and Grade III varicocele and their associations with semen characteristics in men consulting for couple infertility. Asian J Androl 2018;20(4):360–5. http://dx.doi.org/10.4103/aja.aja_78_17.

[124] Horsth C, Akakpo W, Graziana JP, Ferretti L, Yiou R, Morel-Journel N, et al. Recommandations du Comité d'andrologie et de médecine sexuelle de l'AFU concernant la prise en charge de la Varicocele. Prog Urol 2021;31(3):119–30. http://dx.doi.org/10.1016/j.purol.2020.11.006.

[125] Bieth E, Hamdi SM, Mieusset R. Genetics of the congenital absence of the vas deferens. Hum Genet 2021;140(1):59–76. http://dx.doi.org/10.1007/s00439-020-02122-w.

[126] Henkel R, Offor U, Fisher D. The role of infections and leukocytes in male infertility. Andrologia 2021;53(1):e13743. http://dx.doi.org/10.1111/and.13743.

[127] Sharma R, Gupta S, Agarwal A, Henkel R, Finelli R, Parekh N, et al. Relevance of leukocytospermi and semen culture and its true place in diagnosing and treating male infertility. World J Mens Health 2022;40(2):191–207. http://dx.doi.org/10.5534/wjmh.210063.

[128] Calogero AE, Duca Y, Condorelli RA, La Vignera S. Male accessory gland inflammation, infertility, and sexual dysfunctions: a practical approach to diagnosis and therapy. Andrology 2017;5(6):1064–72. http://dx.doi.org/10.1111/andr.12427.

[129] Rowe PJ, World Health Organization, editors. WHO manual for the standardized investigation and diagnosis of the infertile couple. Cambridge: New York: Published on behalf of the World Health Organization by Cambridge University Press; 1993 [83 p.].

[130] Ahmadi MH, Mirsalehian A, Gilani MAS, Bahador A, Talebi M. Improvement of semen parameters after antibiotic therapy in asymptomatic infertile men infected with Mycoplasma genitalium. Infection 2018;46(1):31–8. http://dx.doi.org/10.1007/s15010-017-1075-3.

[131] Ahmadi MH, Mirsalehian A, Sadighi Gilani MA, Bahador A, Talebi M. Asymptomatic infection with mycoplasma hominis negatively affects semen parameters and leads to male infertility as confirmed by improved semen parameters after antibiotic treatment. Urology 2017;100:97–102. http://dx.doi.org/10.1016/j.urology.2016.11.018.

[132] Motamedifar M, Malekzadegan Y, Namdari P, Dehghani B, Jahromi BN, Sarvari J. The prevalence of bacteriospermi in infertile men and association with semen quality in southwestern Iran. Infect Disord Drug Targets 2020;20(2):198–202. http://dx.doi.org/10.2174/1871526519666181123182116.

[133] Huang C, Long X, Jing S, Fan L, Xu K, Wang S, et al. Ureaplasma urealyticum and Mycoplasma hominis infections and semen quality in 19,098 infertile men in China. World J Urol 2016;34(7):1039–44. http://dx.doi.org/10.1007/s00345-015-1724-z [Epub 2015 Nov 4].

[134] Qing L, Song QX, Feng JL, Li HY, Liu G, Jiang HH. Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Ureaplasma urealyticum infections using a novel isothermal simultaneous RNA amplification testing method in infertile males. Ann Clin Microbiol Anti-microb 2017;16(1):45. http://dx.doi.org/10.1186/s12941-017-0220-2.

[135] Moazenchi M, Totonchi M, Salman Yazdi R, Hratian K, Mohseni Meybodi MA, Ahmadi Panah M, et al. The impact of Chlamydia trachomatis infection on sperm parameters and male fertility: a comprehensive study. Int J STD AIDS 2018;29(5):466–73. http://dx.doi.org/10.1177/0956462417735245.

[136] Boeri L, Pederzoli F, Capogrosso P, Abbate C, Alfano M, Mancini N, et al. Semen infections in men with primary infertility in the real-life setting. Fertil Steril 2020;113(6):1174–82. http://dx.doi.org/10.1016/j.fertnstert.2020.01.034.

[137] Kim SJ, Paik DJ, Lee JS, Lee HS, Seo JT, Jeong MS, et al. Effects of infections with five sexually transmitted pathogens on sperm quality. Clin Exp Reprod Med 2017;44(4):207–13. http://dx.doi.org/10.5653/cerm.2017.44.4.207.

[138] Moridi K, Ghazvini K, Hemmaty M, Hoseiniun H, Torkaman M, Fallah Meh-rabadi MH. Prevalence determination of m. Hominis and m. Genitalium in the semen samples in the northeast of Iran using culture and multiplex polymerase chain reaction. Arch Razi Inst 2021;76(1):41–9. http://dx.doi.org/10.22092/ari.2019.125966.1338.

[139] Agarwal A, Farkouh A, Parekh N, Zini A, Arafa M, Kandil H, et al. Sperm DNA fragmentation: a critical assessment of clinical practice guidelines. World J Mens Health 2022;40(1):30–7. http://dx.doi.org/10.5534/wjmh.210056.

[140] Vicari LO, Castiglione R, Salemi M, Vicari BO, Mazzarino MC, Vicari E. Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients. Andrologia 2016;48(4):380–8. http://dx.doi.org/10.1111/and.12456.

[141] Gallegos G, Ramos B, Santiso R, Goyanes V, Gosálvez J, Fernández JL. Sperm DNA fragmentation in infertile men with genitourinary infection by Chlamydia trachomatis and Mycoplasma. Fertil Steril 2008;90(2):328–34. http://dx.doi.org/10.1016/j.fertnstert.2007.06.035.

[142] Bourlet T, Bouchara JP, Galinier JL, editors. Rémic : référentiel en microbiologie médicale. 7ᵉ éd., Paris: Société française de microbiologie; 2022.

[143] Freeman S, Bertolotto M, Richenberg J, Belfield J, Dogra V, Huang DY, et al. Ultrasound evaluation of varicoceles: guidelines and recommendations of the European Society of Urogenital Radiology Scrotal and Penile Imaging Working Group (ESUR-SPIWG) for detection, classification, and grading. Eur Radiol 2020;30(1):11–25. http://dx.doi.org/10.1007/s00330-019-06280-y.

[144] Minhas S, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, et al. European Association of urology guidelines on male sexual and reproductive health: 2021 update on male infertility. Eur Urol 2021;80(5):603–20. http://dx.doi.org/10.1016/j.eururo.2021.08.014.

[145] Lotti F, Frizza F, Balercia G, Carbonetti A, Behre HM, Calogero AE, et al. The European Academy of Andrology (EAA) ultrasound study on healthy, fertile men: an overview on male genital tract ultrasound reference ranges. Andrology 2022;10(Suppl. 2 (Suppl. 2)):118–32.

[146] Handelsman DJ, Staraj S. Testicular size: the effects of aging, malnutrition, and illness. J Androl 1985;6(3):144–51. http://dx.doi.org/10.1002/j.1939-4640.1985.tb00830.x.

[147] Sakamoto H, Saito K, Ogawa Y, Yoshida H. Testicular volume measurements using Prader orchidometer versus ultrasonography in patients with infertility. Urology 2007;69(1):158–62. http://dx.doi.org/10.1016/j.urology.2006.09.013.

[148] Condorelli R, Calogero AE, La Vignera S. Relationship between testicular volume and conventional or nonconventional sperm parameters. Int J Endocrinol 2013;2013:145792. http://dx.doi.org/10.1155/2013/145792.

[149] Sakamoto H, Ogawa Y, Yoshida H. Relationship between testicular volume and testicular function: comparison of the Prader orchidometric and ultrasonographic measurements in patients with infertility. Asian J Androl 2008;10(2):319–24. http://dx.doi.org/10.1111/j.1745-7262.2008.00340.x.

[150] Liguori G, Trombetta C, Garaffa G, Bucci S, Gattuccio I, Salamè L, et al. Color Doppler ultrasound investigation of varicocele. World J Urol 2004;22(5):378–81. http://dx.doi.org/10.1007/s00345-004-0421-0.

[151] Jarow JP. Effects of varicocele on male fertility. Hum Reprod Update 2001;7(1):59–64. http://dx.doi.org/10.1093/humupd/7.1.59.

[152] Bieniek JM, Juvet T, Margolis M, Grober ED, Lo KC, Jarvi KA. Prevalence and management of incidental small testicular masses discovered on ultrasonographic evaluation of male infertility. J Urol 2018;199(2):481–6. http://dx.doi.org/10.1016/j.juro.2017.08.004.

[153] Jacobsen R, Bostofte E, Engholm G, Hansen J, Olsen JH, Skakkebaek NE, et al. Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ 2000;321(7264):789–92. http://dx.doi.org/10.1136/bmj.321.7264.789.

[154] Fedder J, Crüger D, Oestergaard B, Petersen GB. Etiology of azoospermi in 100 consecutive nonvasectomized men. Fertil Steril 2004;82(5):1463–5. http://dx.doi.org/10.1016/j.fertnstert.2004.06.035.

[155] Kassogué A, El Ammari JE, Diarra A, Amiroune D, Ahsaini M, Ouldim K, et al. Agénésie bilatérale des vésicules séminales et des canaux déférents. Can Urol Assoc J 2014;8(7–8):E490–2. http://dx.doi.org/10.5489/cuai.1503.

[156] Singh R, Hamada AJ, Bukavina L, Agarwal A. Physical deformities relevant to male infertility. Nat Rev Urol 2012;9(3):156–74. http://dx.doi.org/10.1038/nrurol.2012.11.

[157] Jequier AM, Ansell ID, Bullimore NJ. Congenital absence of the vasa deferentia presenting with infertility. J Androl 1985;6(1):15–9.

[158] Fedder J, Jørgensen MW, Engvad B. Prevalence of CBAVD in azoospermic men carrying pathogenic CFTR mutations – Evaluated in a cohort of 639 non-vasectomized azoospermic men. Andrology 2021;9(2):588–98. http://dx.doi.org/10.1111/andr.12925.

[159] Schlegel PN, Shin D, Goldstein M. Urogenital anomalies in men with congenital absence of the vas deferens. J Urol 1996;155(5):1644–8.

[160] Ravig G, Mor Y, Levron J, Shefi S, Zilberman D, Ramon J, et al. Role of transrectal ultrasonography in the evaluation of azoospermic men with low-volume ejaculate. J Ultrasound Med 2006;25(7):825–9. http://dx.doi.org/10.7863/jum.2006.25.7.825.

[161] Richenberg J, Belfield J, Ramchandani P, Rocher L, Freeman S, Tsili AC, et al. Testicular microlithiasis imaging and follow-up: guidelines of the ESUR scrotal imaging subcommittee. Eur Radiol 2015;25(2):323–30. http://dx.doi.org/10.1007/s00330-014-3437-x.

[162] Bourcigaux N, Christin-Maître S. Dosages hormonaux chez l'homme infertile. Gynecol Obstet Fertil 2008;36(5):551–6. http://dx.doi.org/10.1016/j.gyobfe.2008.03.006.

[163] McGriff SC, Lo EM, Hotaling JM, Pastuszak AW. Optimal endocrine evaluation and treatment of male infertility. Urol Clin North Am 2020;47(2):139–46. http://dx.doi.org/10.1016/j.ucl.2019.12.002.
C. Sonigo, G. Robin, F. Boiretelle *et al.*

Gynécologie Obstétrique Fertilité & Sénologie xxx (2024) xxx–xxx

[164] Andrade DL, Viana MC, Esteves SC. Differential diagnosis of azoospermia in men with infertility. J Clin Med 2021;10(14):3144. http://dx.doi.org/10.3390/jcm10143144.

[165] Keskin MZ, Budak S, Zeyrek T, Çelik O, Mertoglu O, Yoldas M, et al. The relationship between serum hormone levels (follicle-stimulating hormone, luteinizing hormone, total testosterone) and semen parameters. Arch Ital Urol Androl 2015;87(3):194–7. http://dx.doi.org/10.4081/iaua.2015.3.194.

[166] Jensen TK, Andersson AM, Hjollund NH, Scheike T, Kolstad H, Giwercman A, et al. Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. J Clin Endocrinol Metab 1997;82(12):4059–63. http://dx.doi.org/10.1210/jcem.82.12.4456.

[167] Christman MS, Gudeman SR, Nork JJ, Walters RC, L'Esperance JO, Crain DS. Operating characteristics of follicle-stimulating hormone in azoospermic men. Fertil Steril 2014;101(5):1261–5. http://dx.doi.org/10.1016/j.fertnster.2014.01.034.

[168] Lardone MC, Piottante A, Valdevenito R, Ebensperger M, Castro A. Histological and hormonal testicular function in oligo/azoospermic infertile men. Andrologia 2013;45(6):379–85. http://dx.doi.org/10.1111/and.12026.

[169] Chen SC, Hsieh JT, Yu HJ, Chang HC. Appropriate cut-off value for follicle-stimulating hormone in azoospermia to predict spermatogenesis. Reprod Biol Endocrinol 2010;8:108. http://dx.doi.org/10.1186/1477-7827-8-108.

[170] Mitchell V, Robin G, Boiretelle F, Massart P, Marchetti C, Marcelli F, et al. Correlation between testicular sperm extraction outcomes and clinical, endocrine and testicular histology parameters in 120 azoospermic men with normal serum FSH levels. Int J Androl 2011;34(4):299–305. http://dx.doi.org/10.1111/j.1365-2605.2010.01094.x.

[171] Boiretelle F, Robin G, Marcelli F, Albert M, Leroy-Martin B, Dewailly D, et al. A predictive score for testicular sperm extraction quality and surgical ICSI outcome in non-obstructive azoospermia: a retrospective study. Hum Reprod Oxf Engl 2011;26(12):3215–21. http://dx.doi.org/10.1093/humrep/der314.

[172] Masson P, Brannigan RE. The varicocele. Urol Clin North Am 2014;41(1):129–44. http://dx.doi.org/10.1016/j.ucl.2013.08.001.

[173] Dubin L, Amelar RD. Varicocele size and results of varicocelectomy in selected subfertile men with varicocele. Fertil Steril 1970;21(8):606–9. http://dx.doi.org/10.1016/s0015-0282(16)37684-1.

[174] Baazeem A, Belzile E, Ciampi A, Dahle G, Jarvi K, Salonia A, et al. Varicocele and male factor infertility treatment: a new meta-analysis and review of the role of varicocele repair. Eur Urol 2011;60(4):796–808. http://dx.doi.org/10.1016/j.eurour.2011.06.018.

[175] Birowo P, Rahendra Wijaya J, Atmoko W, Rasyid N. The effects of varicocelectomy on the DNA fragmentation index and other sperm parameters: a meta-analysis. Basic Clin Androl 2020;30:15. http://dx.doi.org/10.1186/s12610-020-00112-6.

[176] Fallara G, Capogrosso P, Pozzi E, Belladelli F, Corsini C, Boeri L, et al. The effect of varicocele treatment on fertility in adults: a systematic review and meta-analysis of published prospective trials. Eur Urol Focus 2023;9(1):154–61. http://dx.doi.org/10.1016/j.euf.2022.08.014.

[177] Schauer I, Madersbacher S, Jost R, Hübner WA, Imhof M. The impact of varicocelectomy on sperm parameters: a meta-analysis. J Urol 2012;187(5):1540–7. http://dx.doi.org/10.1016/j.juro.2011.12.084.

[178] Marmar JL, Agarwal A, Prabakaran S, Agarwal R, Short RA, Benoff S, et al. Reassessing the value of varicocele as a treatment for male subfertility with a new meta-analysis. Fertil Steril 2007;88(3):639–48. http://dx.doi.org/10.1016/j.fertnstert.2006.12.008.

[179] Abdel-Meguid TA, Al-Sayyad A, Tayib A, Farsi HM. Does varicocele repair improve male infertility? An evidence-based perspective from a randomized, controlled trial. Eur Urol 2011;59(3):455–61. http://dx.doi.org/10.1016/j.eurour.2010.12.008.

[180] Daitch JA, Bedaowy MA, Pasqualotto EB, Hendin BN, Hallak J, Falcone T, et al. Varicocelectomy improves intrauterine insemination success rates in men with varicocele. J Urol 2001;165(5):1510–3.

[181] Schlegel PN, Sigman M, Collura B, De Jonge CJ, Eisenberg ML, Lamb DJ, et al. Diagnosis and treatment of infertility in men: AUA/ASRM Guideline Part II. J Urol 2021;205(1):44–51. http://dx.doi.org/10.1097/JU.00000000000001520.

[182] Kirby EW, Wiener LE, Rajanahally S, Crowell K, Coward RM. Undergoing varicocele repair before assisted reproduction improves pregnancy rate and live birth rate in azoospermic and oligospermic men with a varicocele: a systematic review and meta-analysis. Fertil Steril 2016;106(6):1338–43. http://dx.doi.org/10.1016/j.fertnstert.2016.07.1093.

[183] Zini A, Dahle G. Are varicoceles associated with increased deoxyribonucleic acid fragmentation? Fertil Steril 2011;96(6):1283–7. http://dx.doi.org/10.1016/j.fertnstert.2011.10.016.

[184] Smit M, Romijn JC, Wildhagen MF, Veldhoven JLM, Weber RFA, Dahle GR. Decreased sperm DNA fragmentation after surgical varicocelectomy is associated with increased pregnancy rate. J Urol 2013;189(1 Suppl.):S146–50. http://dx.doi.org/10.1016/j.juro.2012.11.024.

[185] Neves da Silva HV, Meller RL, Ogundipe EA, Rochon PJ. Varicoceles: overview of treatment from a radiologic and surgical perspective. Semin Interv Radiol 2022;39(5):490–7. http://dx.doi.org/10.1055/s-0042-1757939.

[186] Ding H, Tian J, Du W, Zhang L, Wang H, Wang Z. Open non-microsurgical, laparoscopic or open microsurgical varicocelectomy for male infertility: a meta-analysis of randomized controlled trials. BJU Int 2012;110(10):1536–42. http://dx.doi.org/10.1111/j.1464-410X.2012.11093.x.

[187] Sampplaski MK, Lo KC, Grober ED, Zini A, Jarvi KA. Varicocelectomy to "upgrade" semen quality to allow couples to use less invasive forms of assisted reproductive technology. Fertil Steril 2017;108(4):609–12. http://dx.doi.org/10.1016/j.fertnstert.2017.07.017.

[188] Rich-Eldwards JW, Spiegelman D, Garland M, Hertzmark E, Hunter DJ, Colditz GA, et al. Physical activity, body mass index, and ovulatory disorder infertility. Epidemiol Camb Mass 2002;13(2):184–90. http://dx.doi.org/10.1097/00001648-200203000-00013.

[189] Belliver J, Marín C, Lathi RB, Murugappan G, Labarta E, Vidal C, et al. Obesity affects endometrial receptivity by displacing the window of implantation. Reprod Sci 2021;28(11):3171–80. http://dx.doi.org/10.1007/s43032-021-00631-1.

[190] Sermondade N, Huberlant S, Bourhis-Lefebvre V, Arbo E, Gallot V, Colombani M, et al. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis. Hum Reprod Update 2019;25(4):439–51. http://dx.doi.org/10.1093/humupd/dmz011.

[191] Bhattacharya S, Campbell DM, Liston WA, Bhattacharya S. Effect of body mass index on pregnancy outcomes in nulliparous women delivering singleton babies. BMC Public Health 2007;7:168. http://dx.doi.org/10.1186/1471-2458-7-168.

[192] Crosignani PG, Colombo M, Vegetti W, Somigliana E, Gessati A, Ragni G. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod 2003;18(9):1928–32. http://dx.doi.org/10.1093/humrep/deg367.

[193] Mutsaerts MAQ, van Oers AM, Groen H, Burggraaff JM, Kuchenbecker WKH, Perquin DM, et al. Randomized trial of a lifestyle program in obese infertile women. N Engl J Med 2016;374(20):1942–53. http://dx.doi.org/10.1056/NEJMoa1505297.

[194] Einarsson S, Bergh C, Friberg B, Pinborg A, Klajnbard A, Karlström PO, et al. Weight reduction intervention for obese infertile women prior to IVF: a randomized controlled trial. Hum Reprod 2017;32(8):1621–30. http://dx.doi.org/10.1093/humrep/dex235.

[195] Kalliala I, Markozannes G, Gunter MJ, Paraskevakidis E, Gabra H, Mitra A, et al. Obesity and gynaecological and obstetric conditions: umbrella review of the literature. BMJ 2017;359:j4511. http://dx.doi.org/10.1136/bmj.j4511.

[196] Grzegorczyk-Martin V, Fréour T, De Bantel Finet A, Bonnet E, Merzouk M, Roset J, et al. IVF outcomes in patients with a history of bariatric surgery: a multicenter retrospective cohort study. Hum Reprod 2020;35(12):2755–62. http://dx.doi.org/10.1093/humrep/deea208.

[197] Benito E, Gómez-Martin JM, Vega-Piñero B, Priego P, Galindo J, Escobar-Morreale HF, et al. Fertility and pregnancy outcomes in women with polycystic ovary syndrome following bariatric surgery. J Clin Endocrinol Metab 2020;105(9):dgaa439. http://dx.doi.org/10.1210/clinem/dgaa439.

[198] Practice Committee of the American Society for Reproductive Medicine. Smoking and infertility: a committee opinion. Fertil Steril 2018;110(4):611–8. http://dx.doi.org/10.1016/j.fertnstert.2018.06.016.

[199] Budani MC, Fensore S, Di Marzio M, Tiboni GM. Cigarette smoking impairs clinical outcomes of assisted reproductive technologies: a meta-analysis of the literature. Reprod Toxicol 2018;80:49–59. http://dx.doi.org/10.1016/j.reprotox.2018.06.001.

[200] Benedict MD, Missmer SA, Vahratian A, Berry KF, Vitonis AF, Cramer DW, et al. Secondhand tobacco smoke exposure is associated with increased risk of failed implantation and reduced IVF success. Hum Reprod 2011;26(9):2525–31. http://dx.doi.org/10.1093/humrep/der226.

[201] Nassan FL, Arvizu M, Mínguez-Alarcón L, Gaskins AJ, Williams PL, Petrozza JC, et al. Marijuana smoking and outcomes of infertility treatment with assisted reproductive technologies. Hum Reprod 2019;34(9):1818–29. http://dx.doi.org/10.1093/humrep/dez098.

[202] Har-Gil E, Heled A, Dixon M, Ahamed AMS, Bentov Y. The relationship between cannabis use and IVF outcome-a cohort study. J Cannabis Res 2021;3(1):42. http://dx.doi.org/10.1186/s42238-021-00099-5.

[203] Nassan FL, Arvizu M, Mínguez-Alarcón L, Gaskins AJ, Williams PL, Petrozza JC, et al. Marijuana smoking and outcomes of infertility treatment with assisted reproductive technologies. Hum Reprod 2019;34(9):1818–29. http://dx.doi.org/10.1093/humrep/dez098.

[204] Gunn JKL, Rosales CB, Center KE, Nuñez A, Gibson SJ, Christ C, et al. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open 2016;6(4):e009986. http://dx.doi.org/10.1136/bmjopen-2015-009986.

[205] Rossi BV, Berry KF, Hornstein MD, Cramer DW, Ehrlich S, Missmer SA. Effect of alcohol consumption on in vitro fertilization. Obstet Gynecol 2011;117(1):136–42. http://dx.doi.org/10.1097/AOG.0b013e31820090e1.

[206] Dodge LE, Missmer SA, Thornton KL, Hacker MR. Women's alcohol consumption and cumulative incidence of live birth following in vitro fertilization. J Assist Reprod Genet 2017;34(7):877–83. http://dx.doi.org/10.1007/s10815-017-0923-5.

[207] Lyngsø J, Ramlau-Hansen CH, Bay B, Ingerslev HJ, Strandberg-Larsen K, Kesmodel US. Low-to-moderate alcohol consumption and success in fertility treatment: a Danish cohort study. Hum Reprod 2019;34(7):1334–44. http://dx.doi.org/10.1093/humrep/dez050.

[208] Ricci E, Noli S, Ferrari S, La Vecchia I, De Cosmi V, Castiglioni M, et al. Pretreatment maternal lifestyle and outcomes of assisted reproduction: an Italian cohort study. BMJ Open 2020;10(11):e038837. http://dx.doi.org/10.1136/bmjopen-2020-038837.
[164] Andrade DL, Viana MC, Esteves SC. Differential diagnosis of azoospermia in men with infertility. J Clin Med 2021;10(14):3144. http://dx.doi.org/10.3390/jcm10143144.

[165] Keskin MZ, Budak S, Zeyrek T, Çelik O, Mertoglu O, Yoldas M, et al. The relationship between serum hormone levels (follicle-stimulating hormone, luteinizing hormone, total testosterone) and semen parameters. Arch Ital Urol Androl 2015;87(3):194-7. http://dx.doi.org/10.4081/iaua.2015.3.194.

[166] Jensen TK, Andersson AM, Hjollund NH, Scheike T, Kolstad H, Giwercman A, et al. Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. J Clin Endocrinol Metab 1997;82(12):4059-63. http://dx.doi.org/10.1210/jcem.82.12.4456.

[167] Christman MS, Gudeman SR, Nork JJ, Walters RC, L'Esperance JO, Crain DS. Operating characteristics of follicle-stimulating hormone in azoospermic men. Fertil Steril 2014;101(5):1261-5. http://dx.doi.org/10.1016/j.fertnster.2014.01.034.

[168] Lardone MC, Piottante A, Valdevenito R, Ebensperger M, Castro A. Histological and hormonal testicular function in oligo/azoospermic infertile men. Andrologia 2013;45(6):379-85. http://dx.doi.org/10.1111/and.12026.

[169] Chen SC, Hsieh JT, Yu HJ, Chang HC. Appropriate cut-off value for follicle-stimulating hormone in azoospermia to predict spermatogenesis. Reprod Biol Endocrinol 2010;8:108. http://dx.doi.org/10.1186/1477-7827-8-108.

[170] Mitchell V, Robin G, Boitrelle F, Massart P, Marchetti C, Marcelli F, et al. Correlation between testicular sperm extraction outcomes and clinical, endocrine and testicular histology parameters in 120 azoospermic men with normal serum FSH levels. Int J Androl 2011;34(4):299-305. http://dx.doi.org/10.1111/j.1365-2605.2010.01094.x.

[171] Boitrelle F, Robin G, Marcelli F, Albert M, Leroy-Martin B, Dewailly D, et al. A predictive score for testicular sperm extraction quality and surgical ICSI outcome in non-obstructive azoospermia: a retrospective study. Hum Reprod Oxf Engl 2011;26(12):3215-21. http://dx.doi.org/10.1093/humrep/der314.

[172] Masson P, Brannigan RE. The varicocele. Urol Clin North Am 2014;41(1):129-44. http://dx.doi.org/10.1016/j.ucl.2013.08.001.

[173] Dubin L, Amelar RD. Varicocele size and results of varicocelectomy in selected subfertile men with varicocele. Fertil Steril 1970;21(8):606-9. http://dx.doi.org/10.1016/s0015-0282(16)37684-1.

[174] Baazeem A, Belzile E, Ciampi A, Dahle G, Jarvi K, Salonia A, et al. Varicocele and male factor infertility treatment: a new meta-analysis and review of the role of varicocele repair. Eur Urol 2011;60(4):796-808. http://dx.doi.org/10.1016/j.eurour.2011.06.018.

[175] Birowo P, Rahendra Wijaya J, Atmoko W, Rasyid N. The effects of varicocelectomy on the DNA fragmentation index and other sperm parameters: a meta-analysis. Basic Clin Androl 2020;30:15. http://dx.doi.org/10.1186/s12610-020-00112-6.

[176] Fallara G, Capogrosso P, Pozzi E, Belladelli F, Corsini C, Boeri L, et al. The effect of varicocele treatment on fertility in adults: a systematic review and meta-analysis of published prospective trials. Eur Urol Focus 2023;9(1):154-61. http://dx.doi.org/10.1016/j.euf.2022.08.014.

[177] Schauer I, Madersbacher S, Jost R, Hübner WA, Imhof M. The impact of varicocelectomy on sperm parameters: a meta-analysis. J Urol 2012;187(5):1540-7. http://dx.doi.org/10.1016/j.juro.2011.12.084.

[178] Marmar JL, Agarwal A, Prabakaran S, Agarwal R, Short RA, Benoff S, et al. Reassessing the value of varicocele treatment as a treatment for male subfertility with a new meta-analysis. Fertil Steril 2007;88(3):639-48. http://dx.doi.org/10.1016/j.fertnstert.2006.12.008.

[179] Abdel-Meguid TA, Al-Sayyad A, Tayib A, Farsi HM. Does varicocele repair improve male infertility? An evidence-based perspective from a randomized, controlled trial. Eur Urol 2011;59(3):455-61. http://dx.doi.org/10.1016/j.eurour.2010.12.008.

[180] Daitch JA, Bedaiwy MA, Pasqualotto EB, Hendin BN, Hallak J, Falcone T, et al. Varicocelectomy improves intrauterine insemination success rates in men with varicocele. J Urol 2001;165(5):1510-3.

[181] Schlegel PN, Sigman M, Collura B, De Jonge CJ, Eisenberg ML, Lamb DJ, et al. Diagnosis and treatment of infertility in men: AUA/ASRM Guideline Part II. J Urol 2021;205(1):44-51. http://dx.doi.org/10.1097/JU.00000000000001520.

[182] Kirby EW, Wiener LE, Rajanahally S, Crowell K, Coward RM. Undergoing varicocele repair before assisted reproduction improves pregnancy rate and live birth rate in azoospermic and oligospermic men with a varicocele: a systematic review and meta-analysis. Fertil Steril 2016;106(6):1338-43. http://dx.doi.org/10.1016/j.fertnstert.2016.07.1093.

[183] Zini A, Dahle G. Are varicoceles associated with increased deoxyribonucleic acid fragmentation? Fertil Steril 2011;96(6):1283-7. http://dx.doi.org/10.1016/j.fertnstert.2011.10.016.

[184] Smit M, Romijn JC, Wildhagen MF, Veldhoven JLM, Weber RFA, Dahle GR. Decreased sperm DNA fragmentation after surgical varicocelectomy is associated with increased pregnancy rate. J Urol 2013;189(1 Suppl.):S146-50. http://dx.doi.org/10.1016/j.juro.2012.11.024.

[185] Neves da Silva HV, Meller RL, Ogundipe EA, Rochon PJ. Varicoceles: overview of treatment from a radiologic and surgical perspective. Semin Interv Radiol 2022;39(5):490-7. http://dx.doi.org/10.1055/s-0042-1757939.

[186] Ding H, Tian J, Du W, Zhang L, Wang H, Wang Z. Open non-microsurgical, laparoscopic or open microsurgical varicocelectomy for male infertility: a meta-analysis of randomized controlled trials. BJU Int 2012;110(10):1536-42. http://dx.doi.org/10.1111/j.1464-410X.2012.11093.x.

[187] Sampplaski MK, Lo KC, Grober ED, Zini A, Jarvi KA. Varicocelectomy to "upgrade" semen quality to allow couples to use less invasive forms of assisted reproductive technology. Fertil Steril 2017;108(4):609-12. http://dx.doi.org/10.1016/j.fertnstert.2017.07.017.

[188] Rich-Eld Edwards JW, Spiegelman D, Garland M, Hertzmark E, Hunter DJ, Colditz GA, et al. Physical activity, body mass index, and ovulatory disorder infertility: Epidemiol Camb Mass 2002;13(2):184-90. http://dx.doi.org/10.1097/00001648-200203000-00013.

[189] Belliver J, Marín C, Lathi RB, Murugappan G, Labarta E, Vidal C, et al. Obesity affects endometrial receptivity by displacing the window of implantation. Reprod Sci 2021;28(11):3171-80. http://dx.doi.org/10.1007/s43032-021-00631-1.

[190] Sermondade N, Huberlant S, Bourhis-Lefebvre V, Arbo E, Gallot V, Colombani M, et al. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis. Hum Reprod Update 2019;25(4):439-51. http://dx.doi.org/10.1093/humupd/dmz011.

[191] Bhattacharya S, Campbell DM, Liston WA, Bhattacharya S. Effect of body mass index on pregnancy outcomes in nulliparous women delivering singleton babies. BMC Public Health 2007;7:168. http://dx.doi.org/10.1186/1471-2458-7-168.

[192] Crosignani PG, Colombo M, Vegetti W, Somigliana E, Gessati A, Ragni G. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod 2003;18(9):1928-32. http://dx.doi.org/10.1093/humrep/deg367.

[193] Mutsaerts MAQ, van Oers AM, Groen H, Burggraaff JM, Kuchenbecker WKH, Perquin DA, et al. Randomized trial of a lifestyle program in obese infertile women. N Engl J Med 2016;374(20):1942-53. http://dx.doi.org/10.1056/NEJMoa1505297.

[194] Einarsson S, Bergh C, Friberg B, Pinborg A, Klajnbard A, Karlström PO, et al. Weight reduction intervention for obese infertile women prior to IVF: a randomized controlled trial. Hum Reprod 2017;32(8):1621-30. http://dx.doi.org/10.1093/humrep/dex235.

[195] Kalliala I, Markozannes G, Gunter MJ, Paraskevakidis E, Gabra H, Mitra A, et al. Obesity and gynaecological and obstetric conditions: umbrella review of the literature. BMJ 2017;359:j4511. http://dx.doi.org/10.1136/bmj.j4511.

[196] Grzegorczyk-Martin V, Fréour T, De Bantel Finet A, Bonnet E, Merzouk M, Roset J, et al. IVF outcomes in patients with a history of bariatric surgery: a multicenter retrospective cohort study. Hum Reprod 2020;35(12):2755-62. http://dx.doi.org/10.1093/humrep/deea208.

[197] Benito E, Gómez-Martin JM, Vega-Piñero B, Priego P, Galindo J, Escobar-Morreale HF, et al. Fertility and pregnancy outcomes in women with polycystic ovary syndrome following bariatric surgery. J Clin Endocrinol Metab 2020;105(9):dgaa439. http://dx.doi.org/10.1210/clinem/dgaa439.

[198] Practice Committee of the American Society for Reproductive Medicine. Smoking and infertility: a committee opinion. Fertil Steril 2018;110(4):611-8. http://dx.doi.org/10.1016/j.fertnstert.2018.06.016.

[199] Budani MC, Fensore S, Di Marzio M, Tiboni GM. Cigarette smoking impairs clinical outcomes of assisted reproductive technologies: a meta-analysis of the literature. Reprod Toxicol 2018;80:49-59. http://dx.doi.org/10.1016/j.reprotox.2018.06.001.

[200] Benedict MD, Missmer SA, Vahratian A, Berry KF, Vitonis AF, Cramer DW, et al. Secondhand tobacco smoke exposure is associated with increased risk of failed implantation and reduced IVF success. Hum Reprod 2011;26(9):2525-31. http://dx.doi.org/10.1093/humrep/der226.

[201] Nassan FL, Arvizu M, Mínguez-Alarcón L, Gaskins AJ, Williams PL, Petrozza JC, et al. Marijuana smoking and outcomes of infertility treatment with assisted reproductive technologies. Hum Reprod 2019;34(9):1818-29. http://dx.doi.org/10.1093/humrep/dez098.

[202] Har-Gil E, Heled A, Dixon M, Ahamed AMS, Bentov Y. The relationship between cannabis use and IVF outcome-a cohort study. J Cannabis Res 2021;3(1):42. http://dx.doi.org/10.1186/s42238-021-00099-5.

[203] Nassan FL, Arvizu M, Mínguez-Alarcón L, Gaskins AJ, Williams PL, Petrozza JC, et al. Marijuana smoking and outcomes of infertility treatment with assisted reproductive technologies. Hum Reprod 2019;34(9):1818-29. http://dx.doi.org/10.1093/humrep/dez098.

[204] Gunn JKL, Rosales CB, Center KE, Nuñez A, Gibson SJ, Christ C, et al. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open 2016;6(4):e009986. http://dx.doi.org/10.1136/bmjopen-2015-009986.

[205] Rossi BV, Berry KF, Hornstein MD, Cramer DW, Ehrlich S, Missmer SA. Effect of alcohol consumption on in vitro fertilization. Obstet Gynecol 2011;117(1):136-42. http://dx.doi.org/10.1097/AOG.0b013e31820090e1.

[206] Dodge LE, Missmer SA, Thornton KL, Hacker MR. Women's alcohol consumption and cumulative incidence of live birth following in vitro fertilization. J Assist Reprod Genet 2017;34(7):877-83. http://dx.doi.org/10.1007/s10815-017-0923-5.

[207] Lyngsø J, Ramlau-Hansen CH, Bay B, Ingerslev HJ, Strandberg-Larsen K, Kesmodel US. Low-to-moderate alcohol consumption and success in fertility treatment: a Danish cohort study. Hum Reprod 2019;34(7):1334-44. http://dx.doi.org/10.1093/humrep/dez050.

[208] Ricci E, Noli S, Ferrari S, La Vecchia I, De Cosmi V, Castiglioni M, et al. Pretreatment maternal lifestyle and outcomes of assisted reproduction: an Italian cohort study. BMJ Open 2020;10(11):e038837. http://dx.doi.org/10.1136/bmjopen-2020-038837.
[209] Popova S, Lange S, Probst C, Gmel G, Rehm J. Estimation of national, regional, global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Lancet Glob Health 2017;5(3):e290–9. http://dx.doi.org/10.1016/S2214-109X(17)30021-9.

[210] Firns S, Cruzat VF, Keane KN, Joesbury KA, Lee AH, Newsholme P, et al. The effect of cigarette smoking, alcohol consumption and fruit and vegetable consumption on IVF outcomes: a review and presentation of original data. Reprod Biol Endocrinol 2015;13:134. http://dx.doi.org/10.1186/s12958-015-0133-x.

[211] Hoek J, Schoenmakers S, Baart EB, Koster MPH, Willemsen SP, van Marion ES, et al. Preconceptional maternal vegetable intake and paternal smoking are associated with pre-implantation embryo quality. Reprod Sci Thousand Oaks Calif 2020;27(11):2018–28. http://dx.doi.org/10.1007/s43032-020-00220-8.

[212] Vanegas JC, Chavarro JE, Williams PL, Ford JB, Toth TL, Hauser R, et al. Discrete survival model analysis of a couple's smoking pattern and outcomes of assisted reproduction. Fertil Res Pract 2017;3(1):5. http://dx.doi.org/10.1186/s40738-017-0032-2.

[213] Gundersen TD, Jørgensen N, Andersson AM, Bang AK, Nordkap L, Skakkebæk NE, et al. Association between use of marijuana and male reproductive hormones and semen quality: a study among 1215 healthy young men. Am J Epidemiol 2015;182(6):473–81. http://dx.doi.org/10.1093/aje/kwv135.

[214] Whan LB, West MCL, McClure N, Lewis SEM. Effects of delta-9-tetrahydro-cannabinol, the primary psychoactive cannabinoid in marijuana, on human sperm function in vitro. Fertil Steril 2006;85(3):653–60. http://dx.doi.org/10.1016/j.fertnstert.2005.08.027.

[215] Kasman AM, Thoma ME, McLain AC, Eisenberg ML. Association between use of marijuana and time to pregnancy in men and women: findings from the National Survey of Family Growth. Fertil Steril 2018;109(5):866–71. http://dx.doi.org/10.1016/j.fertnstert.2018.01.015.

[216] Klonoff-Cohen H, Lam-Kruglick P, Gonzalez C. Effects of maternal and paternal alcohol consumption on the success rates of in vitro fertilization and gamete intrafallopsian transfer. Fertil Steril 2003;79(2):330–9. http://dx.doi.org/10.1016/s0015-0282(02)04582-x.

[217] Grieger JA, Grzeskowiak LE, Bianco-Miotto T, Jankovic-Karasoulos T, Moran LJ, Wilson RL, et al. Pre-pregnancy fast food and fruit intake is associated with time to pregnancy. Hum Reprod 2018;33(6):1063–70. http://dx.doi.org/10.1093/humrep/dey079.

[218] Hatch EE, Wesselink AK, Hahn KA, Michiel JJ, Mikkelsen EM, Sorensen HT, et al. Intake of sugar-sweetened beverages and fecundability in a North American Preconception Cohort. Epidemiology 2018;29(3):369–78. http://dx.doi.org/10.1097/EDE.0000000000000812.

[219] Afeiche MC, Chiu YH, Gaskins AJ, Williams PL, Souter I, Wright DL, et al. Dairy intake in relation to in vitro fertilization outcomes among women from a fertility clinic. Hum Reprod 2016;31(3):563–71. http://dx.doi.org/10.1093/humrep/dev344.

[220] Karayiannis D, Kontogianni MD, Mendorou C, Mastrominas M, Yiannakouris N. Adherence to the Mediterranean diet and IVF success rate among non-obese women attempting fertility. Hum Reprod Oxf Engl 2018;33(3):494–502. http://dx.doi.org/10.1093/humrep/dev003.

[221] Ricci E, Bravi F, Noli S, Somigliana E, Cipriani S, Castiglioni M, et al. Mediterranean diet and outcomes of assisted reproduction: an Italian cohort study. Am J Obstet Gynecol 2019;221(6). http://dx.doi.org/10.1016/j.ajog.2019.07.011 [627.e1–627.e14].

[222] Gaskins AJ, Nassan FL, Chiu YH, Arvizu M, Williams PL, Keller MG, et al. Dietary patterns and outcomes of assisted reproduction. Am J Obstet Gynecol 2019;220(6). http://dx.doi.org/10.1016/j.ajog.2019.02.004 [567.e1–567.e18].

[223] Twigt JM, Bolhuis MEC, Steegers EaP, Hammiche F, van Inzen WG, Laven JSE, et al. The preconception diet is associated with the chance of ongoing pregnancy in women undergoing IVF/ICSI treatment. Hum Reprod 2012;27(8):2526–31. http://dx.doi.org/10.1093/humrep/des157.

[224] Salas-Huetos A, Bulló M, Salas-Salvadó J. Dietary patterns, foods and nutrients in male fertility parameters and fecundability: a systematic review of observational studies. Hum Reprod Update 2017;23(4):371–89. http://dx.doi.org/10.1093/humupp/dmx006.

[225] Braga DP de AF, Halpern G, Figueira R de CS, Setti AS, Iaconelli A, Borges E, et al. Food intake and social habits in male patients and its relationship to intracytoplasmic sperm injection outcomes. Fertil Steril 2012;97(1):53–9. http://dx.doi.org/10.1016/j.fertnstert.2011.10.011.

[226] Foucaut AM, Faure C, Julia C, Czernichow S, Levy R, Dupont C, et al. Sedentary behavior, physical inactivity and body composition in relation to idiopathic infertility among men and women. PLoS One 2019;14(4):e0210770. http://dx.doi.org/10.1371/journal.pone.0210770.

[227] Dhair A, Abed Y. The association of types, intensities and frequencies of physical activity with primary infertility among females in Gaza Strip, Palestine: a case-control study. PLoS One 2020;15(10):e0241043. http://dx.doi.org/10.1371/journal.pone.0241043.

[228] Mena GP, Mielke GI, Brown WJ. Do physical activity, sitting time and body mass index affect fertility over a 15-year period in women? Data from a large population-based cohort study. Hum Reprod 2020;35(3):676–83. http://dx.doi.org/10.1093/humrep/dez300.

[229] Mena GP, Mielke GI, Brown WJ. The effect of physical activity on reproductive health outcomes in young women: a systematic review and meta-analysis. Hum Reprod Update 2019;25(5):541–63. http://dx.doi.org/10.1093/humupp/dmz013.

[230] Gaskins AJ, Afeiche MC, Hauser R, Williams PL, Gillman MW, Tanrikut C, et al. Paternal physical and sedentary activities in relation to semen quality and reproductive outcomes among couples from a fertility center. Hum Reprod 2014;29(11):2575–82. http://dx.doi.org/10.1093/humrep/deu212.

[231] Ibañez-Perez J, Santos-Zorrozua B, Lopez-Lopez E, Matorras R, Garcia-Orad A. An update on the implication of physical activity on semen quality: a systematic review and meta-analysis. Arch Gynecol Obstet 2019;299(4):901–21. http://dx.doi.org/10.1007/s00404-019-05045-8.

[232] Practice Committee of the American Society for Reproductive Medicine. Evidence-based treatments for couples with unexplained infertility: a guideline. Fertil Steril 2020;113(2):305–22. http://dx.doi.org/10.1016/j.fertnstert.2019.10.014.

[233] Badawy A, Shokeir T, Allam AF, Abdelhady H. Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility. Acta Obstet Gynecol Scand 2009;88(2):187–91. http://dx.doi.org/10.1080/00016340802638199.

[234] Hughes E, Brown J, Collins JJ, Vanderkerchove P. Clomiphene citrate for unexplained subfertility in women. Cochrane Database Syst Rev 2010;2010(1):CD000057. http://dx.doi.org/10.1002/14651858.CD000057.pub2.

[235] Veltman-Verhulst SM, Hughes E, Ayeleke RO, Cohlen BJ. Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev 2016;2:CD001838. http://dx.doi.org/10.1002/14651858.CD001838.pub5.

[236] Danhof NA, Wang R, van Wely M, van der Veen F, Mol BWJ, Mochtar MH. IUI for unexplained infertility – a network meta-analysis. Hum Reprod Update 2020;26(1):1–15. http://dx.doi.org/10.1093/humupp/dmz035.

[237] Kocak M, Dilbaz B, Demir B, Taşçı Y, Tarcan A, Dede S, et al. Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study. Gynecol Endocrinol 2010;26(6):429–34. http://dx.doi.org/10.3109/09513591003632175.

[238] Rashidi M, Aaleyasin A, Aghahosseini M, Lolois S, Kokab A, Najmi Z. Advantage-ges of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomised clinical trial in unexplained infertility. Eur J Obstet Gynecol Reprod Biol 2013;169(2):244–7. http://dx.doi.org/10.1016/j.ejogrb.2013.03.002.

[239] Azargoan A, Bahrami M, Alavy Touzy J. Comparing clomiphene citrate plus HMG with clomiphene citrate plus rFSH in IUI cycles in couples with unexplained or male factor infertility: a prospective randomized study. Iran J Reprod Med 2013;11(3):243–8.

[240] Zolton JR, Lindner PG, Terry N, DeCherney AH, Hill MJ. Gonadotropins versus oral ovarian stimulation agents for unexplained infertility: a systematic review and meta-analysis. Fertil Steril 2020;113(2):417–25. http://dx.doi.org/10.1016/j.fertnstert.2019.09.042 [e1].

[241] Ayeleke RO, Asseler JD, Cohlen BJ, Veltman-Verhulst SM. Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev 2020;3(3):CD001838. http://dx.doi.org/10.1002/14651858.CD001838.pub6.

[242] Lizneva D, Suturina L, Walker W, Brakta S, Gavrillova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 2016;106(1):6–15. http://dx.doi.org/10.1016/j.fertnstert.2016.05.003.

[243] Panay N. Progress in understanding and management of premature ovarian insufficiency. Climacteric 2021;24(5):423–4. http://dx.doi.org/10.1080/13697137.2021.1919460.

[244] European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI, Webber L, Davies M, Anderson R, Bartlett J, Braat D, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod 2016;31(5):926–37. http://dx.doi.org/10.1093/humrep/dew027.

[245] Franik S, Kremer JAM, Nelen WLDM, Farquhar C, Marjoribanks J. Aromatase inhibitors for subfertile women with polycystic ovary syndrome: summary of a Cochrane review. Fertil Steril 2015;103(2):353–5. http://dx.doi.org/10.1016/j.fertnstert.2014.10.016.

[246] Roque M, Tostes ACI, Valle M, Sampaio M, Geber S. Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysis. Gynecol Endocrinol 2015;31(12):917–21. http://dx.doi.org/10.3109/0951359015.1096337.

[247] Tsiami AP, Goulis DG, Sotiriadis AI, Kolibianakis EM. Higher ovulation rate with letrozole as compared with clomiphene citrate in infertile women with polycystic ovary syndrome: a systematic review and meta-analysis. Hormones 2021;20(3):449–61. http://dx.doi.org/10.1007/s42000-021-00289-z.

[248] Wang R, Li W, Bordewijk EM, Legro RS, Zhang H, Wu X, et al. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis. Hum Reprod Update 2019;25(6):717–32. http://dx.doi.org/10.1093/humupp/dmz029.

[249] Brown J, Farquhar C. Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome. Cochrane Database Syst Rev 2016;12(12):CD002249. http://dx.doi.org/10.1002/14651858.CD002249.pub5.

[250] Seyedohoshadaei F, Zandvakily F, Shahgeibi S. Comparison of the effectiveness of clomiphene citrate, tamoxifen and letrozole in ovulation induction in infertility due to isolated unovulation. Iran J Reprod Med 2012;10(6):531–6.

[251] Weiss NS, Kostova E, Nahuis M, Mol BWJ, van der Veen F, van Wely M. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2019;1(1):CD010290. http://dx.doi.org/10.1002/14651858.CD010290.pub3.
[209] Popova S, Lange S, Probst C, Gmel G, Rehm J. Estimation of national, regional, global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Lancet Glob Health 2017;5(3):e290-9. http://dx.doi.org/10.1016/S2214-109X(17)30021-9.

[210] Firns S, Cruzat VF, Keane KN, Joesbury KA, Lee AH, Newsholme P, et al. The effect of cigarette smoking, alcohol consumption and fruit and vegetable consumption on IVF outcomes: a review and presentation of original data. Reprod Biol Endocrinol 2015;13:134. http://dx.doi.org/10.1186/s12958-015-0133-x.

[211] Hoek J, Schoenmakers S, Baart EB, Koster MPH, Willemsen SP, van Marion ES, et al. Preconceptional maternal vegetable intake and paternal smoking are associated with pre-implantation embryo quality. Reprod Sci Thousand Oaks Calif 2020;27(11):2018-28. http://dx.doi.org/10.1007/s43032-020-00220-8.

[212] Vanegas JC, Chavarro JE, Williams PL, Ford JB, Toth TL, Hauser R, et al. Discrete survival model analysis of a couple's smoking pattern and outcomes of assisted reproduction. Fertil Res Pract 2017;3(1):5. http://dx.doi.org/10.1186/s40738-017-0032-2.

[213] Gundersen TD, Jørgensen N, Andersson AM, Bang AK, Nordkap L, Skakkebekk NE, et al. Association between use of marijuana and male reproductive hormones and semen quality: a study among 1215 healthy young men. Am J Epidemiol 2015;182(6):473-81. http://dx.doi.org/10.1093/aje/kwv135.

[214] Whan LB, West MCL, McClure N, Lewis SEM. Effects of delta-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in marijuana, on human sperm function in vitro. Fertil Steril 2006;85(3):653-60. http://dx.doi.org/10.1016/j.fertnstert.2005.08.027.

[215] Kasman AM, Thoma ME, McLain AC, Eisenberg ML. Association between use of marijuana and time to pregnancy in men and women: findings from the National Survey of Family Growth. Fertil Steril 2018;109(5):866-71. http://dx.doi.org/10.1016/j.fertnstert.2018.01.015.

[216] Klonoff-Cohen H, Lam-Kruglick P, Gonzalez C. Effects of maternal and paternal alcohol consumption on the success rates of in vitro fertilization and gamete intrafallopidal transfer. Fertil Steril 2003;79(2):330-9. http://dx.doi.org/10.1016/s0015-0282(02)04582-x.

[217] Grieger JA, Grzeskowiak LE, Bianco-Miotto T, Jankovic-Karasoulos T, Moran LJ, Wilson RL, et al. Pre-pregnancy fast food and fruit intake is associated with time to pregnancy. Hum Reprod 2018;33(6):1063-70. http://dx.doi.org/10.1093/humrep/dey079.

[218] Hatch EE, Wesselink AK, Hahn KA, Michiel JJ, Mikkelsen EM, Sorensen HT, et al. Intake of sugar-sweetened beverages and fecundability in a North American Preconception Cohort. Epidemiology 2018;29(3):369-78. http://dx.doi.org/10.1097/EDE.0000000000000812.

[219] Afeiche MC, Chiu YH, Gaskins AJ, Williams PL, Souter I, Wright DL, et al. Dairy intake in relation to in vitro fertilization outcomes among women from a fertility clinic. Hum Reprod 2016;31(3):563-71. http://dx.doi.org/10.1093/humrep/dev344.

[220] Karayiannis D, Kontogianni MD, Mendorou C, Mastrominas M, Yiannakouris N. Adherence to the Mediterranean diet and IVF success rate among non-obese women attempting fertility. Hum Reprod Oxf Engl 2018;33(3):494-502. http://dx.doi.org/10.1093/humrep/dev003.

[221] Ricci E, Bravi F, Noli S, Somigliana E, Cipriani S, Castiglioni M, et al. Mediterranean diet and outcomes of assisted reproduction: an Italian cohort study. Am J Obstet Gynecol 2019;221(6). http://dx.doi.org/10.1016/j.ajog.2019.07.011 [627.e1-627.e14].

[222] Gaskins AJ, Nassan FL, Chiu YH, Arvizu M, Williams PL, Keller MG, et al. Dietary patterns and outcomes of assisted reproduction. Am J Obstet Gynecol 2019;220(6). http://dx.doi.org/10.1016/j.ajog.2019.02.004 [567.e1-567.e18].

[223] Twigt JM, Bolhuis MEC, Steegers EaP, Hammiche F, van Inzen WG, Laven JSE, et al. The preconception diet is associated with the chance of ongoing pregnancy in women undergoing IVF/ICSI treatment. Hum Reprod 2012;27(8):2526-31. http://dx.doi.org/10.1016/j.fertnstert.2011.10.017.

[224] Salas-Huetos A, Bulló M, Salas-Salvadó J. Dietary patterns, foods and nutrients in male fertility parameters and fecundability: a systematic review of observational studies. Hum Reprod Update 2017;23(4):371-89. http://dx.doi.org/10.1093/humupp/dmx006.

[225] Braga DP de AF, Halpern G, Figueira R de CS, Setti AS, Iaconelli A, Borges E, et al. Food intake and social habits in male patients and its relationship to intracytoplasmic sperm injection outcomes. Fertil Steril 2012;97(1):53-9. http://dx.doi.org/10.1016/j.fertnstert.2011.10.011.

[226] Foucaut AM, Faure C, Julia C, Czernichow S, Levy R, Dupont C, et al. Sedentary behavior, physical inactivity and body composition in relation to idiopathic infertility among men and women. PLoS One 2019;14(4):e0210770. http://dx.doi.org/10.1371/journal.pone.0210770.

[227] Dhair A, Abed Y. The association of types, intensities and frequencies of physical activity with primary infertility among females in Gaza Strip, Palestine: a case-control study. PLoS One 2020;15(10):e0241043. http://dx.doi.org/10.1371/journal.pone.0241043.

[228] Mena GP, Mielke GI, Brown WJ. Do physical activity, sitting time and body mass index affect fertility over a 15-year period in women? Data from a large population-based cohort study. Hum Reprod 2020;35(3):676-83. http://dx.doi.org/10.1093/humrep/dez300.

[229] Mena GP, Mielke GI, Brown WJ. The effect of physical activity on reproductive health outcomes in young women: a systematic review and meta-analysis. Hum Reprod Update 2019;25(5):541-63. http://dx.doi.org/10.1093/humupp/dmz013.

[230] Gaskins AJ, Afeiche MC, Hauser R, Williams PL, Gillman MW, Tanrikut C, et al. Paternal physical and sedentary activities in relation to semen quality and reproductive outcomes among couples from a fertility center. Hum Reprod 2014;29(11):2575-82. http://dx.doi.org/10.1093/humrep/deu212.

[231] Ibañez-Perez J, Santos-Zorrozua B, Lopez-Lopez E, Matorras R, Garcia-Orad A. An update on the implication of physical activity on semen quality: a systematic review and meta-analysis. Arch Gynecol Obstet 2019;299(4):901-21. http://dx.doi.org/10.1007/s00404-019-05045-8.

[232] Practice Committee of the American Society for Reproductive Medicine. Evidence-based treatments for couples with unexplained infertility: a guideline. Fertil Steril 2020;113(2):305-22. http://dx.doi.org/10.1016/j.fertnstert.2019.10.014.

[233] Badawy A, Shokeir T, Allam AF, Abdelhady H. Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility. Acta Obstet Gynecol Scand 2009;88(2):187-91. http://dx.doi.org/10.1080/00016340802638199.

[234] Hughes E, Brown J, Collins JJ, Vanderkerchove P. Clomiphene citrate for unexplained subfertility in women. Cochrane Database Syst Rev 2010;2010(1):CD000057. http://dx.doi.org/10.1002/14651858.CD000057.pub2.

[235] Veltman-Verhulst SM, Hughes E, Ayeleke RO, Cohlen BJ. Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev 2016;2:CD001838. http://dx.doi.org/10.1002/14651858.CD001838.pub5.

[236] Danhof NA, Wang R, van Wely M, van der Veen F, Mol BWJ, Mochtar MH. IUI for unexplained infertility – a network meta-analysis. Hum Reprod Update 2020;26(1):1-15. http://dx.doi.org/10.1093/humupp/dmz035.

[237] Kocak M, Dilbaz B, Demir B, Taşçı Y, Tarcan A, Dede S, et al. Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study. Gynecol Endocrinol 2010;26(6):429-34. http://dx.doi.org/10.3109/09513591003632175.

[238] Rashidi M, Aaleyasin A, Aghahosseini M, Lolois S, Kokab A, Najmi Z. Advantagees of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility. Eur J Obstet Gynecol Reprod Biol 2013;169(2):244-7. http://dx.doi.org/10.1016/j.ejogrb.2013.03.002.

[239] Azargoan A, Bahrami M, Alavy Touzy J. Comparing clomiphene citrate plus HMG with clomiphene citrate plus rFSH in IUI cycles in couples with unexplained or male factor infertility: a prospective randomized study. Iran J Reprod Med 2013;11(3):243-8.

[240] Zolton JR, Lindner PG, Terry N, DeCherney AH, Hill MJ. Gonadotropins versus oral ovarian stimulation agents for unexplained infertility: a systematic review and meta-analysis. Fertil Steril 2020;113(2):417-25. http://dx.doi.org/10.1016/j.fertnstert.2019.09.042 [e1].

[241] Ayeleke RO, Asseler JD, Cohlen BJ, Veltman-Verhulst SM. Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev 2020;3(3):CD001838. http://dx.doi.org/10.1002/14651858.CD001838.pub6.

[242] Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 2016;106(1):6-15. http://dx.doi.org/10.1016/j.fertnstert.2016.05.003.

[243] Panay N. Progress in understanding and management of premature ovarian insufficiency. Climacteric 2021;24(5):423-4. http://dx.doi.org/10.1080/13697137.2021.1919460.

[244] European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI, Webber L, Davies M, Anderson R, Bartlett J, Braat D, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod 2016;31(5):926-37. http://dx.doi.org/10.1093/humrep/dew027.

[245] Franik S, Kremer JAM, Nelen WLDM, Farquhar C, Marjoribanks J. Aromatase inhibitors for subfertile women with polycystic ovary syndrome: summary of a Cochrane review. Fertil Steril 2015;103(2):353-5. http://dx.doi.org/10.1016/j.fertnstert.2014.10.016.

[246] Roque M, Tostes ACI, Valle M, Sampaio M, Geber S. Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysis. Gynecol Endocrinol 2015;31(12):917-21. http://dx.doi.org/10.3109/09513590.2015.1096337.

[247] Tsiami AP, Goulis DG, Sotiriadis AI, Kolibianakis EM. Higher ovulation rate with letrozole as compared with clomiphene citrate in infertile women with polycystic ovary syndrome: a systematic review and meta-analysis. Hormones 2021;20(3):449-61. http://dx.doi.org/10.1007/s42000-021-00289-z.

[248] Wang R, Li W, Bordewijk EM, Legro RS, Zhang H, Wu X, et al. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis. Hum Reprod Update 2019;25(6):717-32. http://dx.doi.org/10.1093/humupp/dmz029.

[249] Brown J, Farquhar C. Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome. Cochrane Database Syst Rev 2016;12(12):CD002249. http://dx.doi.org/10.1002/14651858.CD002249.pub5.

[250] Seyedohoshadaei F, Zandvakily F, Shahgeibi S. Comparison of the effectiveness of clomiphene citrate, tamoxifen and letrozole in ovulation induction in infertility due to isolated unovulation. Iran J Reprod Med 2012;10(6):531-6.

[251] Weiss NS, Kostova E, Nahuis M, Mol BWJ, van der Veen F, van Wely M. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2019;1(1):CD010290. http://dx.doi.org/10.1002/14651858.CD010290.pub3.
C. Sonigo, G. Robin, F. Boiretelle *et al.*

Gynécologie Obstétrique Fertilité & Sénologie xxx (2024) xxx–xxx

[252] Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2011;(7):CD007506. http://dx.doi.org/10.1002/14651858.CD007506.pub2.

[253] Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Consensus on women's health aspects of polycystic ovary syndrome (PCOS). Hum Reprod 2012;27(1):14–24. http://dx.doi.org/10.1093/humrep/der396.

[254] Abu Hashim H, Omkar O, Abd Elaal I. Intrauterine insemination versus timed intercourse with clomiphene citrate in polycystic ovary syndrome: a randomized controlled trial. Acta Obstet Gynecol Scand 2011;90(4):344–50. http://dx.doi.org/10.1111/j.1600-0412.2010.01063.x.

[255] Gronier H, Peigné M,atteau-Jonard S, Dewailly D, Robin G. Induction de l'ovulation par administration pulsatile GnRH en 2014: revue de la littérature et synthèse des pratiques courantes. Gynecol Obstet Fertil 2014;42(10):732–40. http://dx.doi.org/10.1016/j.gyobfe.2014.07.017.

[256] Tranoulis A, Laios A, Pampanos A, Yannoukakos D, Loutradis D, Michala L. Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea: a systematic review of the literature and a meta-analysis. Fertil Steril 2018;109(4):708–19. http://dx.doi.org/10.1016/j.fertnstert.2017.12.028.e8.

[257] Dubourdieu S, Fréour T, Dessolle L, Barrière P. Prospective, randomized comparison between pulsatile GnRH therapy and combined gonadotropin (FSH + LH) treatment for ovulation induction in women with hypothalamic amenorrhea and underlying polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2013;168(1):45–8. http://dx.doi.org/10.1016/j.ejogrbr.2012.12.016.

[258] Filicori M, Flamigni C, Dellai P, Cogni G, Michelacci L, Arnone R, et al. Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles. J Clin Endocrinol Metab 1994;79(4):1215–20. http://dx.doi.org/10.1210/jcem.79.4.7962297.

[259] Christou F, Pitteloud N, Gomez F. The induction of ovulation by pulsatile administration of GnRH: an appropriate method in hypothalamic amenorrhea. Gynecol Endocrinol 2017;33(8):598–601. http://dx.doi.org/10.1080/09513590.2017.1296948.

[260] Carone D, Caropreso C, Vitti A, Chiappetta R. Efficacy of different gonadotropin combinations to support ovulation induction in WHO type I anovulation infertility: clinical evidences of human recombinant FSH/human recombinant LH in a 2:1 ratio and highly purified human menopausal gonadotropin stimulation protocols. J Endocrinol Invest 2012;35(11):996–1002. http://dx.doi.org/10.3275/8657.

[261] Messinis IE. Ovulation induction: a mini review. Hum Reprod 2005;20(10):2688–97. http://dx.doi.org/10.1093/humrep/dei128.

[262] van Santbrink EJP, Fauser BCJM. Ovulation induction in normogonadotropic anovulation (PCOS). Best Pract Res Clin Endocrinol Metab 2006;20(2):261–70. http://dx.doi.org/10.1016/j.beem.2006.03.002.

[263] Jacquesson L, Belaisch-Allart J, Ayel JP. L'induction de l'ovulation. J Gynecol Obstet Biol Reprod (Paris) 2010;39(8 Suppl. 2):S67–74. http://dx.doi.org/10.1016/S0368-2315(10)70032-6.

[264] Balen AH. Ovulation induction in the management of anovulatory polycystic ovary syndrome. Mol Cell Endocrinol 2013;373(1–2):77–82. http://dx.doi.org/10.1016/j.mce.2012.10.008.

[265] Birch Petersen K, Pedersen NG, Pedersen AT, Lauritsen MP, la Cour Freiesleben N. Mono-ovulation in women with polycystic ovary syndrome: a clinical review on ovulation induction. Reprod Biomed Online 2016;32(6):563–83. http://dx.doi.org/10.1016/j.rbmo.2016.03.006.

[266] Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008;23(3):462–77. http://dx.doi.org/10.1093/humrep/dem426.

[267] Dumont A, Dewailly D, Plouvier P,atteau-Jonard S, Robin G. Comparison between pulsatile GnRH therapy and gonadotropins for ovulation induction in women with both functional hypothalamic amenorrhea and polycystic ovarian morphology. Gynecol Endocrinol 2016;32(12):999–1004. http://dx.doi.org/10.1080/09513590.2016.1191462.

[268] Bonneau C, Chanelles O, Sifer C, Poncelet C. Use of laparoscopy in unexplained infertility. Eur J Obstet Gynecol Reprod Biol 2012;163(1):57–61. http://dx.doi.org/10.1016/j.ejogrbr.2012.03.036.

[269] Nakagawa K, Ohgi S, Horikawa T, Kojima R, Ito M, Saito H. Laparoscopy should be strongly considered for women with unexplained infertility. J Obstet Gynaecol Res 2007;33(5):665–70. http://dx.doi.org/10.1111/j.1447-0756.2007.00629.x.

[270] Shimizu Y, Yamaguchi W, Takashima A, Kaku S, Kita N, Murakami T. Long-term cumulative pregnancy rate in women with unexplained infertility after laparoscopic surgery followed by in vitro fertilization or in vitro fertilization alone: strategy for unexplained infertility. J Obstet Gynaecol Res 2011;37(5):412–5. http://dx.doi.org/10.1111/j.1447-0756.2010.01369.x.

[271] Yu X, Cai H, Guan J, Zheng X, Han H. Laparoscopic surgery: any role in patients with unexplained infertility and failed in vitro fertilization cycles? Medicine (Baltimore) 2019;98(13):e14957. http://dx.doi.org/10.1097/MD.0000000000014957.

[272] Tanahatoe S, Hompes PGA, Lambalk CB. Accuracy of diagnostic laparoscopy in the infertility work-up before intrauterine insemination. Fertil Steril 2003;79(2):361–6. http://dx.doi.org/10.1016/S0015-0282(02)04686-1.

[273] Practice Committee of the American Society for Reproductive Medicine. Role of tubal surgery in the era of assisted reproductive technology: a committee

opinion. Fertil Steril 2015;103(6):e37–43. http://dx.doi.org/10.1016/j.fertnstert.2015.03.032.

[274] Chu J, Harb HM, Gallos ID, Dhillon R, Al-Rshoud FM, Robinson L, et al. Salpingostomy in the treatment of hydrosalpinx: a systematic review and meta-analysis. Hum Reprod 2015;30(8):1882–95. http://dx.doi.org/10.1093/humrep/dev135.

[275] Watelet A, Guan J. Bilateral hydrosalpinges, what to do: salpingectomy or salpingoplasty? Result of a 480 cases continuous series. Gynecol Obstet Clin Med 2021;1(1):5–8. http://dx.doi.org/10.1016/j.gocm.2020.10.003.

[276] Strandell A, Lindhard A, Waldenström U, Thorburn J, Janson PO, Hamberger L. Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Hum Reprod 1999;14(11):2762–9. http://dx.doi.org/10.1093/humrep/14.11.2762.

[277] Melo P, Georgiou EX, Johnson N, van Voorst SF, Strandell A, Mol BWJ, et al. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev 2020;10(10):CD002125. http://dx.doi.org/10.1002/14651858.CD002125.pub4 [http://doi.wiley.com/10.1002/14651858.CD002125.pub4].

[278] Capmas P, Suarthana E, Tulandi T. Management of hydrosalpinx in the era of assisted reproductive technology: a systematic review and meta-analysis. J Minim Invasive Gynecol 2021;28(3):418–41. http://dx.doi.org/10.1016/j.jmig.2020.08.017.

[279] Ikechebelu JI, Eleje GU, Bhamare P, Joe-Ikechebelu NN, Okafor CD, Akintobi AO. Fertility outcomes following laparoscopy-assisted hysteroscopic fallopian tube cannulation: a preliminary study. Obstet Gynecol Int 2018;2018:1–6. http://dx.doi.org/10.1155/2018/7060459.

[280] Tanaka Y, Tajima H, Sakuraba S, Shimokawa R, Kamei K. Renaissance of surgical recanalization for proximal fallopian tube occlusion: falloposcopic tuboplasty as a promising therapeutic option in tubal infertility. J Minim Invasive Gynecol 2011;18(5):651–9. http://dx.doi.org/10.1016/j.jmig.2011.06.014.

[281] De Silva PM, Chu JJ, Gallos ID, Vidyasagar AT, Robinson L, Coomarasamy A. Fallopian tube catheterization in the treatment of proximal tubal obstruction: a systematic review and meta-analysis. Hum Reprod 2017;32(4):836–52. http://dx.doi.org/10.1093/humrep/dex022.

[282] Casini ML, Rossi F, Agostini R, Unfer V. Effects of the position of fibroids on fertility. Gynecol Endocrinol 2006;22(2):106–9. http://dx.doi.org/10.1080/09513590600604673.

[283] Bosteels J, van Wessel S, Weyers S, Broekmans FJ, D'Hooghe TM, Bongers MY, et al. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities. Cochrane Database Syst Rev 2018;12(12):CD009461. http://dx.doi.org/10.1002/14651858.CD009461.pub4.

[284] Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009;91(4):1215–23. http://dx.doi.org/10.1016/j.fertnstert.2008.01.051.

[285] Pérez-Medina T, Bajo-Arenas J, Salazar F, Redondo T, Sanfrutos L, Alvarez P, et al. Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination: a prospective, randomized study. Hum Reprod juin 2005;20(6):1632–5. http://dx.doi.org/10.1093/humrep/deh822.

[286] Taylor E, Gomel V. The uterus and fertility. Fertil Steril 2008;89(1):1–16. http://dx.doi.org/10.1016/j.fertnstert.2007.09.069.

[287] Stamatellos I, Apostolides A, Stamatopoulos P, Bontis J. Pregnancy rates after hysteroscopic polypectomy depending on the size or number of the polyps. Arch Gynecol Obstet 2008;277(5):395–9. http://dx.doi.org/10.1007/s00404-007-0460-z.

[288] Grynberg M, Gervaise A, Faivre E, Deffieux X, Frydman R, Fernandez H. Treatment of twenty-two patients with complete uterine and vaginal septum. J Minim Invasive Gynecol 2012;19(1):34–9. http://dx.doi.org/10.1016/j.jmig.2011.08.726.

[289] Bendifallah S, Faivre E, Legendre G, Deffieux X, Fernandez H. Metroplasty for AFS Class V and VI septate uterus in patients with infertility or miscarriage: reproductive outcomes study. J Minim Invasive Gynecol 2013;20(2):178–84. http://dx.doi.org/10.1016/j.jmig.2012.11.002.

[290] Rikken JFW, Verhorstert KWJ, Emanuel MH, Bongers MY, Spinder T, Kuchenbecker W, et al. Septum resection in women with a septate uterus: a cohort study. Hum Reprod 2020;35(7):1578–88. http://dx.doi.org/10.1093/humrep/dez284.

[291] Rikken JFW, Kowalik CR, Emanuel MH, Bongers MY, Spinder T, Jansen FW, et al. Septum resection versus expectant management in women with a septate uterus: an international multicentre open-label randomized controlled trial. Hum Reprod 2021;36(5):1260–7. http://dx.doi.org/10.1093/humrep/deab037.

[292] Pabuçcu R, Gomel V. Reproductive outcome after hysteroscopic metroplasty in women with septate uterus and otherwise unexplained infertility. Fertil Steril 2004;81(6):1675–8. http://dx.doi.org/10.1016/j.fertnstert.2003.10.035.

[293] Alonso Pacheco L, Laganà AS, Garzon S, Pérez Garrido A, Flores Gornés A, Ghezzi F. Hysteroscopic outpatient metroplasty for T-shaped uterus in women with reproductive failure: results from a large prospective cohort study. Eur J Obstet Gynecol Reprod Biol 2019;243:173–8. http://dx.doi.org/10.1016/j.ejogrbr.2019.09.023.

[294] Roy KK, Baruah J, Sharma JB, Kumar S, Kachawa G, Singh N. Reproductive outcome following hysteroscopic adhesiolysis in patients with infertility due
[252] Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2011;(7):CD007506. http://dx.doi.org/10.1002/14651858.CD007506.pub2.

[253] Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Consensus on women's health aspects of polycystic ovary syndrome (PCOS). Hum Reprod 2012;27(1):14-24. http://dx.doi.org/10.1093/humrep/der396.

[254] Abu Hashim H, Omkar O, Abd Eelaal I. Intrauterine insemination versus timed intercourse with clomiphene citrate in polycystic ovary syndrome: a randomized controlled trial. Acta Obstet Gynecol Scand 2011;90(4):344-50. http://dx.doi.org/10.1111/j.1600-0412.2010.01063.x.

[255] Gronier H, Peigné M,atteau-Jonard S, Dewailly D, Robin G. Induction de l'ovulation par administration pulsatile GnRH en 2014: revue de la littérature et synthèse des pratiques courantes. Gynecol Obstet Fertil 2014;42(10):732-40. http://dx.doi.org/10.1016/j.gyobfe.2014.07.017.

[256] Tranoulis A, Laios A, Pampanos A, Yannoukakos D, Loutradis D, Michala L. Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea: a systematic review of the literature and a meta-analysis. Fertil Steril 2018;109(4):708-19. http://dx.doi.org/10.1016/j.fertnstert.2017.12.028 [e8].

[257] Dubourdieu S, Fréour T, Dessolle L, Barrière P. Prospective, randomized comparison between pulsatile GnRH therapy and combined gonadotropin (FSH + LH) treatment for ovulation induction in women with hypothalamic amenorrhea and underlying polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2013;168(1):45-8. http://dx.doi.org/10.1016/j.ejogrbr.2012.12.016.

[258] Filicori M, Flamigni C, Dellai P, Cogni G, Michelacci L, Arnone R, et al. Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles. J Clin Endocrinol Metab 1994;79(4):1215-20. http://dx.doi.org/10.1210/jcem.79.4.7962297.

[259] Christou F, Pitteloud N, Gomez F. The induction of ovulation by pulsatile administration of GnRH: an appropriate method in hypothalamic amenorrhea. Gynecol Endocrinol 2017;33(8):598-601. http://dx.doi.org/10.1080/09513590.2017.1296948.

[260] Carone D, Caropreso C, Vitti A, Chiappetta R. Efficacy of different gonadotropin combinations to support ovulation induction in WHO type I anovulation infertility: clinical evidences of human recombinant FSH/human recombinant LH in a 2:1 ratio and highly purified human menopausal gonadotropin stimulation protocols. J Endocrinol Invest 2012;35(11):996-1002. http://dx.doi.org/10.3275/8657.

[261] Messinis IE. Ovulation induction: a mini review. Hum Reprod 2005;20(10):2688-97. http://dx.doi.org/10.1093/humrep/dei128.

[262] van Santbrink EJP, Fauser BCJM. Ovulation induction in normogonadotropic anovulation (PCOS). Best Pract Res Clin Endocrinol Metab 2006;20(2):261-70. http://dx.doi.org/10.1016/j.beem.2006.03.002.

[263] Jacquesson L, Belaisch-Allart J, Ayel JP. L'induction de l'ovulation. J Gynecol Obstet Biol Reprod (Paris) 2010;39(8 Suppl. 2):S67-74. http://dx.doi.org/10.1016/S0368-2315(10)70032-6.

[264] Balen AH. Ovulation induction in the management of anovulatory polycystic ovary syndrome. Mol Cell Endocrinol 2013;373(1-2):77-82. http://dx.doi.org/10.1016/j.mce.2012.10.008.

[265] Birch Petersen K, Pedersen NG, Pedersen AT, Lauritsen MP, la Cour Freiesleben N. Mono-ovulation in women with polycystic ovary syndrome: a clinical review on ovulation induction. Reprod Biomed Online 2016;32(6):563-83. http://dx.doi.org/10.1016/j.rbmo.2016.03.006.

[266] Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008;23(3):462-77. http://dx.doi.org/10.1093/humrep/ dem426.

[267] Dumont A, Dewailly D, Plouvier P,atteau-Jonard S, Robin G. Comparison between pulsatile GnRH therapy and gonadotropins for ovulation induction in women with both functional hypothalamic amenorrhea and polycystic ovarian morphology. Gynecol Endocrinol 2016;32(12):999-1004. http://dx.doi.org/10.1080/09513590.2016.1191462.

[268] Bonneau C, Chanelles O, Sifer C, Poncelet C. Use of laparoscopy in unexplained infertility. Eur J Obstet Gynecol Reprod Biol 2012;163(1):57-61. http://dx.doi.org/10.1016/j.ejogrbr.2012.03.036.

[269] Nakagawa K, Ohgi S, Horikawa T, Kojima R, Ito M, Saito H. Laparoscopy should be strongly considered for women with unexplained infertility. J Obstet Gynaecol Res 2007;33(5):665-70. http://dx.doi.org/10.1111/j.1447-0756.2007.00629.x.

[270] Shimizu Y, Yamaguchi W, Takashima A, Kaku S, Kita N, Murakami T. Long-term cumulative pregnancy rate in women with unexplained infertility after laparoscopic surgery followed by in vitro fertilization or in vitro fertilization alone: strategy for unexplained infertility. J Obstet Gynaecol Res 2011;37(5):412-5. http://dx.doi.org/10.1111/j.1447-0756.2010.01369.x.

[271] Yu X, Cai H, Guan J, Zheng X, Han H. Laparoscopic surgery: any role in patients with unexplained infertility and failed in vitro fertilization cycles? Medicine (Baltimore) 2019;98(13):e14957. http://dx.doi.org/10.1097/MD.0000000000014957.

[272] Tanahatoe S, Hompes PGA, Lambalk CB. Accuracy of diagnostic laparoscopy in the infertility work-up before intrauterine insemination. Fertil Steril 2003;79(2):361-6. http://dx.doi.org/10.1016/S0015-0282(02)04686-1.

[273] Practice Committee of the American Society for Reproductive Medicine. Role of tubal surgery in the era of assisted reproductive technology: a committee

opinion. Fertil Steril 2015;103(6):e37-43. http://dx.doi.org/10.1016/j.fertnstert.2015.03.032.

[274] Chu J, Harb HM, Gallos ID, Dhillon R, Al-Rshoud FM, Robinson L, et al. Salpingostomy in the treatment of hydrosalpinx: a systematic review and meta-analysis. Hum Reprod 2015;30(8):1882-95. http://dx.doi.org/10.1093/humrep/dev135.

[275] Watelet A, Guan J. Bilateral hydrosalpinges, what to do: salpingectomy or salpingoplasty? Result of a 480 cases continuous series. Gynecol Obstet Clin Med 2021;1(1):5-8. http://dx.doi.org/10.1016/j.gocm.2020.10.003.

[276] Strandell A, Lindhard A, Waldenström U, Thorburn J, Janson PO, Hamberger L. Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Hum Reprod 1999;14(11):2762-9. http://dx.doi.org/10.1093/humrep/14.11.2762.

[277] Melo P, Georgiou EX, Johnson N, van Voorst SF, Strandell A, Mol BWJ, et al. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev 2020;10(10):CD002125. http://dx.doi.org/10.1002/14651858.CD002125.pub4 [http://doi.wiley.com/10.1002/14651858.CD002125.pub4].

[278] Capmas P, Suarthana E, Tulandi T. Management of hydrosalpinx in the era of assisted reproductive technology: a systematic review and meta-analysis. J Minim Invasive Gynecol 2021;28(3):418-41. http://dx.doi.org/10.1016/j.jmig.2020.08.017.

[279] Ikechebelu JI, Eleje GU, Bhamare P, Joe-Ikechebelu NN, Okafor CD, Akintobi AO. Fertility outcomes following laparoscopy-assisted hysteroscopic fallopian tube cannulation: a preliminary study. Obstet Gynecol Int 2018;2018:1-6. http://dx.doi.org/10.1155/2018/7060459.

[280] Tanaka Y, Tajima H, Sakuraba S, Shimokawa R, Kamei K. Renaissance of surgical recanalization for proximal fallopian tube occlusion: falloposcopic tuboplasty as a promising therapeutic option in tubal infertility. J Minim Invasive Gynecol 2011;18(5):651-9. http://dx.doi.org/10.1016/j.jmig.2011.06.014.

[281] De Silva PM, Chu JJ, Gallos ID, Vidyasagar AT, Robinson L, Coomarasamy A. Fallopian tube catheterization in the treatment of proximal tubal obstruction: a systematic review and meta-analysis. Hum Reprod 2017;32(4):836-52. http://dx.doi.org/10.1093/humrep/dex022.

[282] Casini ML, Rossi F, Agostini R, Unfer V. Effects of the position of fibroids on fertility. Gynecol Endocrinol 2006;22(2):106-9. http://dx.doi.org/10.1080/09513590600604673.

[283] Bosteels J, van Wessel S, Weyers S, Broekmans FJ, D'Hooghe TM, Bongers MY, et al. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities. Cochrane Database Syst Rev 2018;12(12):CD009461. http://dx.doi.org/10.1002/14651858.CD009461.pub4.

[284] Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009;91(4):1215-23. http://dx.doi.org/10.1016/j.fertnstert.2008.01.051.

[285] Pérez-Medina T, Bajo-Arenas J, Salazar F, Redondo T, Sanfrutos L, Alvarez P, et al. Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination: a prospective, randomized study. Hum Reprod juin 2005;20(6):1632-5. http://dx.doi.org/10.1093/humrep/deh822.

[286] Taylor E, Gomel V. The uterus and fertility. Fertil Steril 2008;89(1):1-16. http://dx.doi.org/10.1016/j.fertnstert.2007.09.069.

[287] Stamatellos I, Apostolides A, Stamatopoulos P, Bontis J. Pregnancy rates after hysteroscopic polypectomy depending on the size or number of the polyps. Arch Gynecol Obstet 2008;277(5):395-9. http://dx.doi.org/10.1007/s00404-007-0460-z.

[288] Grynberg M, Gervaise A, Faivre E, Deffieux X, Frydman R, Fernandez H. Treatment of twenty-two patients with complete uterine and vaginal septum. J Minim Invasive Gynecol 2012;19(1):34-9. http://dx.doi.org/10.1016/j.jmig.2011.08.726.

[289] Bendifallah S, Faivre E, Legendre G, Deffieux X, Fernandez H. Metroplasty for AFS Class V and VI septate uterus in patients with infertility or miscarriage: reproductive outcomes study. J Minim Invasive Gynecol 2013;20(2):178-84. http://dx.doi.org/10.1016/j.jmig.2012.11.002.

[290] Rikken JFW, Verhorstert KWJ, Emanuel MH, Bongers MY, Spinder T, Kuchenbecker W, et al. Septum resection in women with a septate uterus: a cohort study. Hum Reprod 2020;35(7):1578-88. http://dx.doi.org/10.1093/humrep/dez284.

[291] Rikken JFW, Kowalik CR, Emanuel MH, Bongers MY, Spinder T, Jansen FW, et al. Septum resection versus expectant management in women with a septate uterus: an international multicentre open-label randomized controlled trial. Hum Reprod 2021;36(5):1260-7. http://dx.doi.org/10.1093/humrep/deab037.

[292] Pabuçcu R, Gomel V. Reproductive outcome after hysteroscopic metroplasty in women with septate uterus and otherwise unexplained infertility. Fertil Steril 2004;81(6):1675-8. http://dx.doi.org/10.1016/j.fertnstert.2003.10.035.

[293] Alonso Pacheco L, Laganà AS, Garzon S, Pérez Garrido A, Flores Gornés A, Ghezzi F. Hysteroscopic outpatient metroplasty for T-shaped uterus in women with reproductive failure: results from a large prospective cohort study. Eur J Obstet Gynecol Reprod Biol 2019;243:173-8. http://dx.doi.org/10.1016/j.ejogrbr.2019.09.023.

[294] Roy KK, Baruah J, Sharma JB, Kumar S, Kachawa G, Singh N. Reproductive outcome following hysteroscopic adhesiolysis in patients with infertility due
C. Sonigo, G. Robin, F. Boitrelle et al.

Gynécologie Obstétrique Fertilité & Sénologie xxx (2024) xxx–xxx

to Asherman's syndrome. Arch Gynecol Obstet 2010;281(2):355-61. http://dx.doi.org/10.1007/s00404-009-1117-x.

[295] March CM. Management of Asherman's syndrome. Reprod Biomed Online 2011;23(1):63-76. http://dx.doi.org/10.1016/j.rbmo.2010.11.018.

[296] Brown K, Tkacz Z. Hysteroscopic and laparoscopic management of caesarean scar (niche) defects in symptomatic patients. J Obstet Gynaecol 2018;38(5):730. http://dx.doi.org/10.1080/01443615.2018.1444394.

[297] Xie H, Wu Y, Yu F, He M, Cao M, Yao S. A comparison of vaginal surgery and operative hysteroscopy for the treatment of cesarean-induced isthmocoele: a retrospective review. Gynecol Obstet Invest 2014;77(2):78-83. http://dx.doi.org/10.1159/000356961.
to Asherman's syndrome. Arch Gynecol Obstet 2010;281(2):355-61. http://dx.doi.org/10.1007/s00404-009-1117-x.

[295] March CM. Management of Asherman's syndrome. Reprod Biomed Online 2011;23(1):63-76. http://dx.doi.org/10.1016/j.rbmo.2010.11.018.

[296] Brown K, Tkacz Z. Hysteroscopic and laparoscopic management of caesarean scar (niche) defects in symptomatic patients. J Obstet Gynaecol 2018;38(5):730. http://dx.doi.org/10.1080/01443615.2018.1444394.

[297] Xie H, Wu Y, Yu F, He M, Cao M, Yao S. A comparison of vaginal surgery and operative hysteroscopy for the treatment of cesarean-induced isthmocele: a retrospective review. Gynecol Obstet Invest 2014;77(2):78-83. http://dx.doi.org/10.1159/000356961.